The NI Formulary Endocrine chapter has been reviewed and is currently out for consultation.
Please send comments to medicines.management@hscni.net by Friday 11th August 2023
Note – as per agreed process the pharmaceutical industry can provide feedback on factual inaccuracies and scientific interpretation only.